Glow-in-the-Dark dye could simplify vulvar cancer surgery
NCT ID NCT06035068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test whether a fluorescent dye called indocyanine green (ICG), used with a special handheld camera, can find sentinel lymph nodes as well as the standard blue dye in early-stage vulvar cancer. Ten patients will receive both dyes during surgery, and doctors will compare how often each method spots the nodes. If ICG works just as well, it could make the procedure simpler and more accessible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Indocyanine green (ICG) dye
What this could lead to
If it works, this could offer a simpler, less invasive way to map lymph nodes in vulvar cancer, potentially making the procedure easier for patients and doctors.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to everyone. The ICG method might not be as accurate as the standard blue dye approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVA CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact